



@article {2274,
	title = {Characterization of polymeric solutions as injectable vehicles for hydroxyapatite microspheres},
	journal = {AAPS PharmSciTechAAPS PharmSciTech},
	volume = {11},
	year = {2010},
	note = {Cited By (since 1996): 1Export Date: 21 November 2012Source: Scopusdoi: 10.1208/s12249-010-9447-3PubMed ID: 20490958Language of Original Document: EnglishCorrespondence Address: Oliveira, S. M.; Dep. de Eng. Mec{\^a}nica e Gest{\~a}o Industrial, Escola Superior de Tecnologia e Gest{\~a}o de Viseu, Campus Polit{\'e}cnico de Repeses, 3504-510, Viseu, Portugal; email: soliveira@estv.ipv.ptChemicals/CAS: alginic acid, 28961-37-7, 29894-36-8, 9005-32-7, 9005-38-3; carboxymethylcellulose, 8050-38-2, 9000-11-7, 9004-32-4, 9050-04-8; hydroxyapatite, 1306-06-5, 51198-94-8; hydroxypropylmethylcellulose, 9004-65-3; Biocompatible Materials; Capsules; Durapatite, 1306-06-5; Excipients; Polymers; Solutions; VehiclesReferences: Verlaan, J.J., Oner, F.C., Dhert, W.J., Anterior spinal column augmentation with injectable bone cements (2006) Biomat, 27 (3), pp. 290-301;Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M.D., Hoemann, C.D., Novel injectable neutral solutions of chitosan form biodegradable gels in situ (2000) Biomat, 21 (21), pp. 2155-2161; 
Hoemann, C.D., Sun, J., Legare, A., McKee, M.D., Buschmann, M.D., Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle (2005) Osteoarthritis Cart., 13 (4), pp. 318-329; 
Balakrishnan, B., Jayakrishnan, A., Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds (2005) Biomat, 26 (18), pp. 3941-3951; 
Shu, X.Z., Ghosh, K., Liu, Y., Palumbo, F.S., Luo, Y., Clark, R.A., Attachment and spreading of fibroblasts on an RGD peptidemodified injectable hyaluronan hydrogel (2004) J. Biomed. Mater. Res., 68 A (2), pp. 365-375; 
Shu, X.Z., Ahmad, S., Liu, Y., Prestwich, G.D., Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering (2006) J. Biomed. Mater. Res. A, 79 (4), pp. 902-912; 
Weiss, P., Gauthier, O., Bouler, J.-M., Grimandi, G., Daculsi, G., Injectable bone substitute using a hydrophilic polymer (1999) Bone, 25 (SUPPL. 1), pp. 67S-70S. , DOI 10.1016/S8756-3282(99)00146-5, PII S8756328299001465; 
Trojani, C., Weiss, P., Michiels, J.F., Vinatier, C., Guicheux, J., Daculsi, G., Three-dimensional culture and differentiation of human osteogenic cells in an injectable hydroxypropylmethylcellulose hydrogel (2005) Biomat, 26 (27), pp. 5509-5517; 
Virto, M.R., Frutos, P., Torrado, S., Frutos, G., Gentamicin release from modified acrylic bone cements with lactose and hydroxypropylmethylcellulose (2003) Biomat, 24 (1), pp. 79-87; 
Bodic, F., Amouriq, Y., Gayet-Delacroix, M., Gauthier, O., Bouler, J.-M., Daculsi, G., M{\'e}thode nom invasive d{\textquoteright}evaluation d{\textquoteright}un substitut osseux injectable/Non-invasive evaluation of an injectable bone substitute (2002) C R Biologies, 325, pp. 345-353; 
Andrews, G.P., Gorman, S.P., Jones, D.S., Rheological characterisation of primary and binary interactive bioadhesive gels composed of cellulose derivatives designed as ophthalmic viscosurgical devices (2005) Biomat, 26 (5), pp. 571-580; 
He, S., Yaszemski, M.J., Yasko, A.W., Engel, P.S., Mikos, A.G., Injectable biodegradable polymer composites based on poly (propylene fumarate) crosslinked with poly (ethylene glycol) dimethacrylate (2000) Biomat, 21 (23), pp. 2389-2394; 
Temenoff, J.S., Mikos, A.G., Injectable biodegradable materials for orthopedic tissue engineering (2000) Biomat, 21 (23), pp. 2405-2412; 
Iooss, P., Le Ray, A.M., Grimandi, G., Daculsi, G., Merle, C., A new injectable bone substitute combining poly (epsilon-caprolactone) microparticles with biphasic calcium phosphate granules (2001) Biomat, 22 (20), pp. 2785-2794; 
Uda, H., Sugawara, Y., Nakasu, M., Experimental studies on hydroxyapatite powder-carboxymethyl chitin composite: Injectable material for bone augmentation (2006) J. Plast. Reconstr. Aesthet. Surg., 59 (2), pp. 188-196; 
Carrodeguas, R.G., Lasa, B.V., Barrio, J.S.D., Injectable acrylic bone cements for vertebroplasty with improved properties (2004) J. Biomed. Mater. Res. B-Appl. Biomat., 68 (1), pp. 94-104; 
Oliveira, S.M., Barrias, C.C., Ribeiro, C.C., Almeida, I.F., Bahia, M.F., Barbosa, M.A., Morphology and mechanical properties of injectable ceramic microspheres (2009) Key Engineering Mat., 396-398, pp. 691-694; 
Barrias, C.C., Ribeiro, C.C., Barbosa, M.A., Adhesion and proliferation of human osteoblastic cells seeded on injectable hydroxyapatite microspheres (2004) Key Engineering Mat., 254-256, pp. 877-880; 
Ribeiro, C.C., Barrias, C.C., Barbosa, M.A., Preparation and characterisation of calcium-phosphate porous microspheres with a uniform size for biomedical applications (2006) J. Mater. Sci. Mater. Med., 17 (5), pp. 455-463; 
Oliveira, S.M., Barrias, C.C., Almeida, I.F., Costa, P.C., Ferreira, M.P., Bahia, M.F., Injectability of a bone filler system based on hydroxyapatite microspheres and a vehicle with in situ gelforming ability (2008) J. Biomed. Mater. Res. B-Appl. Biomat., 87 B, pp. 49-58; 
Barnes, H.A., Hutton, J.F., Walters, K., (1998) An Introduction to Rheology, , Amsterdam: Elsevier Science; 
Leo, W.J., McLoughlin, A.J., Malone, D.M., Effects of sterilization treatments on some properties of alginate solutions and gels (1990) Biotech. Progress, 6 (1), pp. 51-53; 
Holme, H.K., Lindmo, K., Kristiansen, A., Smidsr{\o}d, O., Thermal depolymerization of alginate in the solid state (2003) Carbohydrate Polym., 54 (4), pp. 431-438; 
Bohner, M., Baroud, G., Injectability of calcium phosphate pastes (2005) Biomat, 26 (13), pp. 1553-1563; 
Hide, I.G., Gangi, A., Percutaneous vertebroplasty: History, technique and current perspectives (2004) Clin. Radiol., 59 (6), pp. 461-467; 
Lewis, G., Injectable bone cements for use in vertebroplasty and kyphoplasty: State-of-the-art review (2006) J. Biomed. Mat. Res. B-Appl. Biomat., 76 B (2), pp. 456-468; 
Baumann, A., Tauss, J., Baumann, G., Tomka, M., Hessinger, M., Tiesenhausen, K., Cement embolization into the vena cava and pulmonal arteries after vertebroplasty: Interdisciplinary management (2006) Europ J. Vasc. and End Surg., 31 (5), pp. 558-561; 
Mathis, J.M., Wong, W., Percutaneous vertebroplasty: Technical considerations (2003) J. Vasc. and Intervent Rad., 14 (8), pp. 953-960; 
Xu, H.H., Weir, M.D., Burguera, E.F., Fraser, A.M., Injectable and macroporous calcium phosphate cement scaffold (2006) Biomat, 27 (24), pp. 4279-4287; 
Gisep, A., Curtis, R., Hanni, M., Suhm, N., Augmentation of implant purchase with bone cements: An in vitro study of injectability and dough distribution (2006) J. Biomed. Mater. Res. B-Appl. Biomat., 77 (1), pp. 114-119; 
Krebs, J., Ferguson, S.J., Bohner, M., Baroud, G., Steffen, T., Heini, P.F., Clinical measurements of cement injection pressure during vertebroplasty (2005) Spine, 30 (5), pp. E118-E122; 
Draget, K.I., Skjak-Braek, G., Smidsrod, O., Alginate-based new materials (1997) Int. J. Biol. Macromol., 21 (1-2), pp. 47-55
},
	month = {2010///},
	pages = {852 - 858},
	abstract = {A polymeric solution and a reinforcement phase can work as an injectable material to fill up bone defects. However, the properties of the solution should be suitable to enable the transport of that extra phase. Additionally, the use of biocompatible materials is a requirement for tissue regeneration. Thus, we intended to optimize a biocompatible polymeric solution able to carry hydroxyapatite microspheres into bone defects using an orthopedic injectable device. To achieve that goal, polymers usually regarded as biocompatible were selected, namely sodium carboxymethylcellulose, hydroxypropylmethylcellulose, and Na-alginate (ALG). The rheological properties of the polymeric solutions at different concentrations were assessed by viscosimetry before and after moist heat sterilization. In order to correlate rheological properties with injectability, solutions were tested using an orthopedic device applied for minimal invasive surgeries. Among the three polymers, ALG solutions presented the most suitable properties for our goal and a non-sterile ALG 6\% solution was successfully used to perform preliminary injection tests of hydroxyapatite microspheres. Sterile ALG 7.25\% solution was found to closely match non-sterile ALG 6\% properties and it was selected as the optimal vehicle. Finally, sterile ALG 7.25\% physical stability was studied at different temperatures over a 3-month period. It was observed that its rheological properties presented minor changes when stored at 25{\textdegree}C or at 4{\textdegree}C. {\textcopyright} 2010 American Association of Pharmaceutical Scientists.},
	keywords = {Alginate, alginic acid, article, Biocompatibility, Biocompatible Materials, Capsules, Carboxymethylcellulose, Drug Compounding, Durapatite, Excipients, hydroxyapatite, Hydroxypropylmethylcellulose, Injectability, injection, Injections, instrument sterilization, microsphere, Microspheres, minimally invasive surgery, molecular weight, orthopedic equipment, Polymers, priority journal, Solutions, Vehicles, viscometry},
	isbn = {15309932 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-77954819260\&partnerID=40\&md5=e8503462fa39dcc285aef7e07f765eef},
	author = {Oliveira, S.M. and Almeida, I.F. and Costa, P.C. and Barrias, C.C. and Ferreira, M.R.P. and Bahia, M.F. and Barbosa, M.A.}
}
@article {2336,
	title = {Injectability of a bone filler system based on hydroxyapatite microspheres and a vehicle with in situ gel-forming ability},
	journal = {Journal of Biomedical Materials Research - Part B Applied BiomaterialsJ. Biomed. Mater. Res. Part B Appl. Biomater.},
	volume = {87},
	year = {2008},
	note = {Cited By (since 1996): 9Export Date: 21 November 2012Source: ScopusCODEN: JBMRGdoi: 10.1002/jbm.b.31066PubMed ID: 18437700Language of Original Document: EnglishCorrespondence Address: Oliveira, S. M.; Escola Superior de Tecnologia de Viseu (ESTV), Dep. de Eng. Mec{\^a}nica e Gest{\~a}o Industrial, 3504-510 Viseu, Portugal; email: serafim@ineb.up.ptChemicals/CAS: alginic acid, 28961-37-7, 29894-36-8, 9005-32-7, 9005-38-3; calcium carbonate, 13397-26-7, 13701-58-1, 14791-73-2, 471-34-1; gluconolactonase, 9012-44-6, 9012-73-1; hydroxyapatite, 1306-06-5, 51198-94-8; Bone Substitutes; Durapatite, 1306-06-5; GelsTradenames: Captal S, Plasma BiotalManufacturers: Plasma BiotalReferences: Ribeiro, C.C., Barrias, C.C., Barbosa, M.A., Calcium phosphate-alginate microspheres as enzyme delivery matrices (2004) Biomaterials, 25, pp. 4363-4373;Grabowski, G.A., Leslie, N., Wenstrup, R., Enzyme therapy for Gaucher disease: The first 5 years (1998) Blood Rev, 12, pp. 115-133; 
Melton, L.J., Melton, L.J., Kan, S.H., Frye, M.A., Wahner, H.W., O{\textquoteright}Fallon, W.M., Riggs, B.L., Epidemiology of vertebral fractures in women (1989) Am J Epidemiol, 129, pp. 1000-1011; 
Carrodeguas, R.G., Lasa, B.V., Del Barrio, J.S., injectable acrylic bone cements for vertebroplasty with improved properties (2004) J Biomed Mater Res B Appl Biomater, 68, pp. 94-104; 
Hee, H.T., Percutaneous vertebroplasty: Current concepts and local experience (2005) Neurol India, 53, pp. 475-482; 
Hide, I.G., Gangi, A., Percutaneous vertebroplasty: History, technique and current perspectives (2004) Clin Radiol, 59, pp. 461-467; 
Verlaan, J.J., Oner, F.C., Verbout, A.J., Dhert, W.J., Temperature elevation after vertebroplasty with polymethylmethacrylate in the goat spine (2003) J Biomed Mater Res B Appl Biomater, 67, pp. 581-585; 
Hardouin, P., Grados, F., Cotten, A., Cortet, B., Should percutaneous vertebroplasty be used to treat osteoporotic fractures? An update (2001) Joint Bone Spine, 68, pp. 216-221; 
Berlemann, U., Ferguson, S.J., Nolte, L.P., Heini, P.F., Adjacent vertebral failure after vertebroplasty. A biomechanical investigation (2002) J Bone Joint Surg Br, 84, pp. 748-752; 
Wilcox, R.K., The biomechanical effect of vertebroplasty on the adjacent vertebral body: A finite element study (2006) Proc Inst Mech Eng [H], 220, pp. 565-572; 
Uppin, A.A., Hirsch, J.A., Centenera, L.V., Pfiefer, B.A., Pazianos, A.G., Choi, I.S., Occurrence of new vertebral body fracture after percutaneous vertebroplasty in patients with osteoporosis (2003) Radiology, 226, pp. 119-124; 
Barrias, C.C., Ribeiro, C.C., Barbosa, M.A., Adhesion and proliferation of human osteoblastic cells seeded on injectable hydroxyapatite microspheres (2004) Bioceramics, 254, pp. 877-880; 
Becker, T.A., Kipke, D.R., Brandon, T., Calcium alginate gel: A biocompatible and mechanically stable polymer for endovascular embolization (2001) J Biomed Mater Res, 54, pp. 76-86; 
Alsberg, E., Anderson, K.W., Albeiruti, A., Franceschi, R.T., Mooney, D.J., Cell-interactive alginate hydrogels for bone tissue engineering (2001) J Dent Res, 80, pp. 2025-2029; 
Steinert, A., Weber, M., Dimmler, A., Julius, C., Schutze, N., Noth, U., Cramer, H., Hendrich, C., Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh-viscosity alginate (2003) J Orthop Res, 21, pp. 1090-1097; 
Wang, L., Shelton, R.M., Cooper, P.R., Lawson, M., Triffitt, J.T., Barralet, J.E., Evaluation of sodium alginate for bone marrow cell tissue engineering (2003) Biomaterials, 24, pp. 3475-3481; 
Shapiro, L., Cohen, S., Novel alginate sponges for cell culture and transplantation (1997) Biomaterials, 18, pp. 583-590; 
Eiselt, P., Yeh, J., Latvala, R.K., Shea, L.D., Mooney, D.J., Porous carriers for biomedical applications based on alginate hydrogels (2000) Biomaterials, 21, pp. 1921-1927; 
Wee, S., Gombotz, W.R., Protein release from alginate matrices (1998) Adv Drug Deliv Rev, 31, pp. 267-285; 
Draget, K.I., Skjak-Braek, G., Smidsrod, O., Alginate based new materials (1997) Int J Biol Macromol, 21, pp. 47-55; 
Bajpai, S.K., Sharma, S., Investigation of swelling/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ ions (2004) React Funct Polym, 59, pp. 129-140; 
Ouwerx, C., Velings, N., Mestdagh, M.M., Axelos, M.A.V., Physico-chemical properties and rheology of alginate gel beads formed with various divalent cations (1998) Polym Gels Networks, 6, pp. 393-408; 
Paul, W., Sharma, C.P., Development of porous spherical hydroxyapatite granules: Application towards protein delivery (1999) J Mater Sci Mater Med, 10, pp. 383-388; 
Jarcho, M., Calcium-phosphate ceramics as hard tissue prosthetics (1981) Clin Orthop Relat Res, 157, pp. 259-278; 
Uda, H., Sugawara, Y., Nakasu, M., Experimental studies on hydroxyapatite powder-carboxymethyl chitin composite: Injectable material for bone augmentation (2006) Br J Plast Surg, 59, pp. 188-196; 
Xu, H.H., Weir, M.D., Burguera, E.F., Fraser, A.M., Injectable and macroporous calcium phosphate cement scaffold (2006) Biomaterials, 27, pp. 4279-4287; 
Weiss, P., Gauthier, O., Bouler, J.M., Grimandi, G., Daculsi, G., Injectable bone substitute using a hydrophilic polymer (1999) Bone, 25, pp. 67S-70S; 
Iooss, P., Le Ray, A.M., Grimandi, G., Daculsi, G., Merle, C., A new injectable bone substitute combining poly(epsilon-caprolactone) microparticles with biphasic calcium phosphate granules (2001) Biomaterials, 22, pp. 2785-2794; 
Gauthier, O., Khairoun, I., Bosco, J., Obadia, L., Bourges, X., Rau, C., Magne, D., Weiss, P., Noninvasive bone replacement with a new injectable calcium phosphate biomaterial (2000) J Biomed Mater Res A, 66, pp. 47-54; 
Kuo, C.K., Ma, P.X., Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering, Part 1: Structure, gelation rate and mechanical properties (2001) Biomaterials, 22, pp. 511-521; 
Oakenfull, D., Scott, A., Stabilization of gelatin by sugars and polyols (1986) Food Hydrocolloyds, 1, pp. 163-175; 
Poon, C.Y., Tonicity, O., Osmolality and Osmolarity (2006) Philadelphia: The Science and Practice of Pharmacy, pp. 250-265. , 21st ed; 
Gauthier, O., Bouler, J.M., Weiss, P., Bosco, J., Aguado, E., Daculsi, G., Short-term effects of mineral particle sizes on cellular degradation activity after implantation of injectable calcium phosphate biomaterials and the consequences for bone substitution (1999) Bone, 25, pp. 71S-74S; 
Gisep, A., Curtis, R., Hanni, M., Suhm, N., Augmentation of implant purchase with bone cements: An in vitro study of injectability and dough distribution (2006) J Biomed Mater Res B Appl Biomater, 77, pp. 114-119; 
Ginebra, M.P., Rilliard, A., Fernandez, E., Elvira, C., San Roman, J., Planell, J.A., Mechanical and rheological improvement of a calcium phosphate cement by the addition of a polymeric drug (2001) J Biomed Mater Res, 57, pp. 113-118; 
Krebs, J., Ferguson, S.J., Bohner, M., Baroud, G., Steffen, T., Heini, P.F., Clinical measurements of cement injection pressure during vertebroplasty (2005) Spine, 30, pp. E118-E122; 
Bohner, M., Baroud, G., Injectability of calcium phosphate pastes (2005) Biomaterials, 26, pp. 1553-1563; 
Hernandez, L., Gurruchaga, M., Goni, I., Influence of powder particle size distribution on complex viscosity and other properties of acrylic bone cement for vertebroplasty and kyphoplasty (2006) J Biomed Mater Res B Appl Biomater, 77, pp. 98-103; 
Yoshimine, F., Latta, L.L., Milne, E.L., Sliding characteristics of compression hip screws in the intertrochanteric fracture: A clinical study (1993) J Orthop Trauma, 7, pp. 348-353; 
Jasper, L.E., Deramond, H., Mathis, J.M., Belkoff, S.M., Material properties of various cements for use with vertebroplasty (2002) J Mater Sci Mater Med, 13, pp. 1-5
},
	month = {2008///},
	pages = {49 - 58},
	abstract = {The aim of this study was to test the injectability of a bone filler system based on the combination of ceramic microspheres with a gel-like vehicle, for noninvasive surgery. Porous hydroxyapatite microspheres with a uniform size and an average diameter of 535 {\textpm} 38 μm were prepared, and their compression strength and friability were tested. The sodium-alginate solution with a concentration of 7.25\% (w/v) was used as the vehicle. To promote its in situ gelation, calcium carbonate and D-gluconic-δ-lactone were added to the solution. Microspheres were mixed with the vehicle at different percentages (20-40 wt \%). Gelation times in the range of 8-20 min, were obtained, depending on the formulation. Mixtures of HAp microspheres with alginate solution at 7.25\% originating a gel in 11 min present an adequate handling time to perform an injection. Their injectability was evaluated using an injection device commonly employed in vertebroplasty surgical procedures, coupled to a texturometer in compression mode. Using an extrusion rate of 0.1 mm/s, the force required to extrude any of the mixtures tested was lower than 100 N. For an extrusion rate of 1 mm/s mixtures with 40 wt \% of microspheres were very difficult to inject. Mixtures with 35 wt \% of microspheres presented the best compromise between injectability and compression strength of the gelled system. MicroCT analysis revealed a homogeneous distribution of the microspheres inside the vehicle, as well as full interconnection of the intra-microspheres spaces. The compression strength for the gelled systems ranged from 80 kPa (gel itself) to 600 kPa (composite with 40 Wt \% of microspheres). {\textcopyright} 2008 Wiley Periodicals, Inc.},
	keywords = {Alginate, alginic acid, Apatite, article, Average diameter, bioengineering, Bone, bone filler system, Bone Substitutes, Calcium, Calcium carbonate, Ceramic, Ceramic microspheres, Coagulation, Colloids, compression, Compression mode, Compression strengths, Compressive Strength, Computerized tomography, Concentration (process), Data compression, Durapatite, Extrusion, Extrusion rates, Fillers, Forming, Gel-forming ability, Gelation, Gels, gluconolactonase, Handling time, Homogeneous distribution, hydrogel, hydroxyapatite, In situ gelation, in situ hybridization, In-situ, Injectability, injection, Injection (oil wells), Micro-CT, microsphere, Microspheres, Mixtures, non invasive procedure, Particle Size, Porous hydroxyapatite, Sodium, Surgery, Surgical procedures, Uniform size, Vehicles, Vertebroplasty},
	isbn = {15524973 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-52449123139\&partnerID=40\&md5=cc648bad01cb2c6aa01d885acac10e8a},
	author = {Oliveira, S.M. and Barrias, C.C. and Almeida, I.F. and Costa, P.C. and Pena Ferreira, M.R. and Bahia, M.F. and Barbosa, M.A.}
}
